282 related articles for article (PubMed ID: 23669590)
1. Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults.
Puig L; de la Cueva P; Linares M; Suarez J; Velasco M; Vidal D; Zulaica A; García-Calvo C
Actas Dermosifiliogr; 2013 Jun; 104(5):400-8. PubMed ID: 23669590
[TBL] [Abstract][Full Text] [Related]
2. Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Puig L; Carrascosa JM; Carretero G; de la Cueva P; Lafuente-Urrez RF; Belinchón I; Sánchez-Regaña M; García-Bustínduy M; Ribera M; Alsina M; Ferrándiz C; Fonseca E; García-Patos V; Herrera E; López-Estebaranz JL; Marrón SE; Moreno JC; Notario J; Rivera R; Rodriguez-Cerdeira C; Romero A; Ruiz-Villaverde R; Taberner R; Vidal D;
Actas Dermosifiliogr; 2013 Oct; 104(8):694-709. PubMed ID: 24018211
[TBL] [Abstract][Full Text] [Related]
3. [Opinion of Spanish dermatologists regarding the use of biologic therapy in patients with moderate to severe psoriasis].
Ara M; Pérez A; Ferrando J
Actas Dermosifiliogr; 2011 Nov; 102(9):706-16. PubMed ID: 21600532
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of moderate-to-severe psoriasis in clinical practice: a survey of Spanish dermatologists].
Moreno-Ramírez D; Fonseca E; Herranz P; Ara M
Actas Dermosifiliogr; 2010 Dec; 101(10):858-65. PubMed ID: 21159262
[TBL] [Abstract][Full Text] [Related]
5. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Daudén E; Puig L; Ferrándiz C; Sánchez-Carazo JL; Hernanz-Hermosa JM;
J Eur Acad Dermatol Venereol; 2016 Mar; 30 Suppl 2():1-18. PubMed ID: 26812550
[TBL] [Abstract][Full Text] [Related]
6. Management of Moderate to Severe Psoriasis in Routine Clinical Practice in Spanish Hospitals.
López-Estebaranz JL; de la Cueva-Dobao P; de la Torre Fraga C; Galán Gutiérrez M; González Guerra E; Mollet Sánchez J; Belinchón Romero I
Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):631-642. PubMed ID: 29891209
[TBL] [Abstract][Full Text] [Related]
7. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.
Guibal F; Iversen L; Puig L; Strohal R; Williams P
Curr Med Res Opin; 2009 Dec; 25(12):2835-43. PubMed ID: 19916728
[TBL] [Abstract][Full Text] [Related]
8. [Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents].
Puig L; Carrascosa JM; Daudén E; Sánchez-Carazo JL; Ferrándiz C; Sánchez-Regaña M; García-Bustinduy M; Bordas X; Moreno JC; Hernanz JM; Laguarda S; García-Patos V;
Actas Dermosifiliogr; 2009 Jun; 100(5):386-413. PubMed ID: 19558918
[TBL] [Abstract][Full Text] [Related]
9. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital].
Adnot-Desanlis L; Brochot P; Eschard JP; Bernard P; Reguiaï Z
Ann Dermatol Venereol; 2012 May; 139(5):355-62. PubMed ID: 22578339
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists.
Patel V; Horn EJ; Lobosco SJ; Fox KM; Stevens SR; Lebwohl M
J Am Acad Dermatol; 2008 Jun; 58(6):964-9. PubMed ID: 18378352
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.
Wakkee M; Lugtenberg M; Spuls PI; de Jong EM; Thio HB; Westert GP; Nijsten T
Br J Dermatol; 2008 Aug; 159(2):426-32. PubMed ID: 18616791
[TBL] [Abstract][Full Text] [Related]
13. Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2 - Management of Special Populations, Patients With Comorbid Conditions, and Risk.
Carrascosa JM; Puig L; Romero IB; Salgado-Boquete L; Del Alcázar E; Lencina JJA; Moreno D; de la Cueva P
Actas Dermosifiliogr; 2022 Jun; 113(6):583-609. PubMed ID: 35570005
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].
Vañó-Galván S; Gárate MT; Fleta-Asín B; Hidalgo A; Fernández-Guarino M; Bermejo T; Jaén P
Actas Dermosifiliogr; 2012 Mar; 103(2):127-37. PubMed ID: 22036021
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of clinical use of etanercept for the treatment of moderate-to-severe psoriasis in Spain: results of a multicentric prospective study at 12 months follow-up.
Puig L; Camacho Martínez FM; Gimeno Carpio E; López-Ávila A; García-Calvo C
Dermatology; 2012; 225(3):220-30. PubMed ID: 23235195
[TBL] [Abstract][Full Text] [Related]
16. Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
Berends MA; de Jong EM; van de Kerkhof PC; Gerritsen MJ
Dermatology; 2007; 215(1):45-52. PubMed ID: 17587839
[TBL] [Abstract][Full Text] [Related]
17. Biologic agents in nail psoriasis: efficacy data and considerations.
Kyriakou A; Patsatsi A; Sotiriadis D
Expert Opin Biol Ther; 2013 Dec; 13(12):1707-14. PubMed ID: 24156504
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate for psoriasis: current European practice. A postal survey.
Boffa MJ
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
[TBL] [Abstract][Full Text] [Related]
19. Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists.
Fallah Arani S; Balak DM; Neumann HA; Kuipers MV; Thio HB
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):972-5. PubMed ID: 23822581
[TBL] [Abstract][Full Text] [Related]
20. Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register.
Iskandar IY; Ashcroft DM; Warren RB; Yiu ZZ; McElhone K; Lunt M; Barker JN; Burden AD; Ormerod AD; Reynolds NJ; Smith CH; Griffiths CE
Br J Dermatol; 2015 Aug; 173(2):510-8. PubMed ID: 25989336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
